MONALEESA7 Results from phase III trial looking at ribociclib as an addition to endocrine therapy in advanced breast cancer

MONALEESA-7: Results from phase III trial looking at ribociclib as an addition to endocrine therapy in advanced breast cancer

15:45 EDT 1 Jun 2019 | ecancermedicalscience

Dr Sara A. Hurvitz talks to ecancer at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting about results from the MONALEESA-7 study into adding ribociclib to first-line endocrine therapy in pre-menopausal women with advanced breast...

More From BioPortfolio on "MONALEESA-7: Results from phase III trial looking at ribociclib as an addition to endocrine therapy in advanced breast cancer"